These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25638519)

  • 21. Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease.
    Wasmer K; Unrath M; Köbe J; Malyar NM; Freisinger E; Meyborg M; Breithardt G; Eckardt L; Reinecke H
    Int J Cardiol; 2015 Nov; 199():223-8. PubMed ID: 26209823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute pulmonary embolism registry in the Małopolska region - clinical course.
    Kukla P; Bryniarski L; Długopolski R; Krupa E; Nowak J; Kulak L; Mirek-Bryniarska E; Nowicka A; Hybel J; Szczuka K
    Kardiol Pol; 2009 Jul; 67(7):735-41. PubMed ID: 19649995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
    Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah AS; Habib RH
    Circulation; 2005 Nov; 112(21):3247-55. PubMed ID: 16286585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation.
    Choudhary MB; Holmqvist F; Carlson J; Nilsson HJ; Roijer A; Platonov PG
    Europace; 2013 Oct; 15(10):1445-52. PubMed ID: 23515337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic Pulmonary Embolism after Ablation.
    Guler GB; Can MM; Guler E; Akinci T; Sogukpinar O; Hatipoglu S; Kilicaslan F; Serebruany VL
    Cardiology; 2016; 134(4):426-32. PubMed ID: 27144590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management).
    Gattellari M; Goumas C; Aitken R; Worthington JM
    Cerebrovasc Dis; 2011; 32(4):370-82. PubMed ID: 21921601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of recurrences of new atrial fibrillation in acute myocardial infarction.
    Asanin M; Perunicic J; Mrdovic I; Matic M; Vujisic-Tesic B; Arandjelovic A; Vojvodic A; Marinkovic J; Ostojic M; Vasiljevic Z
    Int J Cardiol; 2006 May; 109(2):235-40. PubMed ID: 16005995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of preoperative echocardiography in the prediction of postoperative atrial fibrillation following isolated coronary artery bypass grafting.
    Açil T; Cölkesen Y; Türköz R; Sezgin AT; Baltali M; Gülcan O; Demircan S; Yildirir A; Ozin B; Müderrisoğlu H
    Am J Cardiol; 2007 Nov; 100(9):1383-6. PubMed ID: 17950794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of atrial fibrillation in acute coronary syndromes.
    Torres M; Rocha S; Marques J; Nabais S; Rebelo A; Pereira MA; Azevedo P; Correia A
    Rev Port Cardiol; 2008 Nov; 27(11):1407-18. PubMed ID: 19227808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atrial fibrillation in medical intensive care unit patients: characteristics and consequences].
    Baumfeld Y; Novack V; Almog Y
    Harefuah; 2013 Sep; 152(9):520-3, 564. PubMed ID: 24364091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation.
    Al Khdair D; Alshengeiti L; Elbarouni B; Yan RT; Grondin FR; Spencer FA; Pallie S; Brieger D; Eagle KA; Mangat I; Singh S; Goodman SG; Yan AT;
    Can J Cardiol; 2012; 28(4):443-9. PubMed ID: 22439969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
    Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
    Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.
    Acharya T; Tringali S; Bhullar M; Nalbandyan M; Ilineni VK; Carbajal E; Deedwania P
    Am J Cardiol; 2015 Dec; 116(12):1852-7. PubMed ID: 26611122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population.
    Eranti A; Aro AL; Kerola T; Anttonen O; Rissanen HA; Tikkanen JT; Junttila MJ; Kenttä TV; Knekt P; Huikuri HV
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1116-21. PubMed ID: 25381332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.